Back to top
more

Gilead Sciences (GILD)

(Delayed Data from NSDQ)

$86.72 USD

86.72
4,365,080

-0.64 (-0.73%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $86.73 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (87 out of 250)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Stock Market News for July 07, 2016

Benchmarks ended in the green on Wednesday after the FOMC minutes from June meeting showed that most of the Fed policymakers were in favor of keeping rates unchanged.

    Sheraz Mian headshot

    Top 6 Research Reports for June 29, 2016

    Today's must-read reports are for Amgen (AMGN), Kraft Heinz (KHC) and United Parcel (UPS).

      Stock Market News for May 02, 2016

      Benchmarks closed in the red on Friday following dismal earnings results, which had a negative impact on biotech stocks

        5 Biotech Stocks to Bet on This Earnings Season

        The happening biotech sector should be a good bet for investors.

          Sheraz Mian headshot

          Making Sense of the Q1 Earnings Reports

          The deceleration in negative estimate revisions could be a positive development on the earnings front.

            Stock Market News for March 22, 2012

            Gains in healthcare and telecom stocks helped the benchmarks end marginally higher on Monday.

              Stock Market News for March 16, 2016

              Benchmarks ended mostly in the red following losses in healthcare and biotech stocks. Further, continuing decline in oil prices also weighed on key U.S. indexes

                Brian Bolan headshot

                Best Growth Stocks In The S&P 500

                Growth is hard to find in this market, but here is a list of four big caps still growing revenues.

                  Brian Bolan headshot

                  Best Growth Stocks In The S&P 500

                  Growth is challenged right now, but these large caps are still increasing revenues in a big way.

                    4 Biotech Stocks Looking Good this Earnings Season

                    the market sentiment seems to be improving driven by upgraded guidance, product approvals and encouraging pipeline updates.

                      Arpita Dutt headshot

                      Pharma Industry Outlook: Pricing Pressure and M&As in Focus

                      According to a tracking poll, most Americans (72%) find drug costs unreasonable and 74% are of the view that drug companies put profits before people.

                        Arpita Dutt headshot

                        Pharma Industry Outlook: Pricing Pressure and M&As in Focus

                        According to a tracking poll, most Americans (72%) find drug costs unreasonable and 74% are of the view that drug companies put profits before people.

                          Kevin Matras headshot

                          PEG Ratio vs. the P/E Ratio

                          Kevin Matras compares the PEG ratio to the P/E ratio and shows how to use them both for finding classically undervalued stocks with market beating growth rates. Highlighted stocks include CALM, EXPR, TSO, BBW and GILD.

                            Kevin Matras headshot

                            What is Your Stock's Earnings Yield?

                            This week, Kevin Matras talks about a stock's Earnings Yield and how to use it. Highlighted stocks include GILD, GT, KRA, ACM and TNK.

                              Kevin Matras headshot

                              PEG Ratio vs. the P/E Ratio

                              Kevin Matras compares the PEG ratio to the P/E ratio and shows how to use them both for finding classically undervalued stocks with market beating growth rates. Highlighted stocks include OUTR, GILD, LIOX, SIMO and WNC.

                                Sheraz Mian headshot

                                Retail Sector in the Spotlight

                                The retail environment is difficult, with consumers hesitant to spend their energy savings.

                                  Sheraz Mian headshot

                                  Retail Sector in the Spotlight

                                  The retail environment is difficult, with consumers hesitant to spend their energy savings.

                                    Kevin Matras headshot

                                    R-Squared Growth Rate: You Need to Know This

                                    Kevin Matras writes about the R-Squared Growth Rate and how it can help you find outperforming stocks. Highlighted stocks include GILD, C and BCS.

                                      Sheraz Mian headshot

                                      Standout Sectors of Q1 Earnings Season

                                      The earnings picture emerging from the Q1 earnings season has been very bad.

                                        Sheraz Mian headshot

                                        Standout Sectors of Q1 Earnings Season

                                        The earnings picture emerging from the Q1 earnings season has been very bad.

                                          Sheraz Mian headshot

                                          Q1 Earnings Scorecard - The Dollar Impact

                                          Small-cap stocks do have an advantage in limited exposure to the strong U.S. dollar.

                                            Sheraz Mian headshot

                                            Q1 Earnings Season Ramps Up

                                            We have enough bellwethers from other sectors to give us a good sense of this earnings season.

                                              Sheraz Mian headshot

                                              Q1 Earnings Season in Spotlight as Alcoa (AA) Reports Results

                                              Market participants will be looking for Alcoa's commentary about the state of global aluminum demand.

                                                Sheraz Mian headshot

                                                What to Look for This Earnings Season

                                                Earnings growth has turned negative for the first half of the year and remains barely in the positive territory in the back half.

                                                  Sheraz Mian headshot

                                                  What to Look for This Earnings Season

                                                  Earnings growth has turned negative for the first half of the year and remains barely in the positive territory in the back half.